Nasdaq · Healthcare
Acadia Healthcare Company, Inc. (ACHC)
As-reported financials and recent SEC filings for Acadia Healthcare Company, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$3.31B
Net income
$-1.10B
Net margin
-33.3%
Diluted EPS
$-12.16
ROE
-56.6%
P/E (TTM)
—
Market cap
$2.52B
Debt / equity
1.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $-1.10B | $255.6M | $-21.7M | $273.1M | $190.6M |
| Diluted EPS | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →8-K2026-05-18
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →S-82026-05-11
View on EDGAR →32026-05-11
View on EDGAR →SCHEDULE 13G/A2026-05-11
View on EDGAR →42026-05-08
View on EDGAR →Go deeper on ACHC
Search Acadia Healthcare Company, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.